Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study

Journal of Clinical and Experimental Hepatology 2026 Open access

Read full text
Authors: Narendra Singh Choudhary, Ajay Duseja, De Arka, Manu Mehta, S.P. Singh, Prajna Anirvan, Shrikant Mukewar, Sourabh Mukewar, Shalimar, Sanjib Kar, Omesh Goyal, Rakhi Maiwall
+26 more Jayanthi Venkataraman, Krishnadas Devadas, V.K. Dixit, Varun Mehta, Piyush Ranjan, Aabha Nagral, Anil Arora, Arun Valsan, Dr Sunil Kumar Dadhich, Brij Sharma, Rohit Gupta, Sandeep Nijhawan, Akash Roy, Dibya Lochan Praharaj, P. Nagaraja Rao, Akash Shukla, Rajiv Mehta, Pankaj Asati, Sanjeev Saigal, K. Narayanasamy, Mallika Bhattacharya, V. G. Mohan Prasad, Abraham Koshy, Mukul Rastogi, Seema Alam, Arun J. Sanyal
DOI: 10.1016/j.jceh.2025.103468
Cited by: 2
References: 21

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Diabetes Cardiovascular Risks and Lipoproteins Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Journal of Clinical and Experimental Hepatology
Publisher
Elsevier BV
Volume
16
Issue
2
Pages
103468–103468
Publication date
7 January 2026
Language
EN